Emcure Pharmaceuticals' Kurkumbh Facility Gets USFDA's VAI Rating, EIR Issued Following Inspection

Unknown Apr 02, 2026 600 Views

Emcure Pharmaceuticals Ltd. announced that the US Food and Drug Administration (USFDA) has categorized its recent inspection of the company's API manufacturing facility at Kurkumbh as VAI (Voluntary Action Indicated), and has issued an Establishment Inspection Report (EIR) accordingly. &n...